1-5 of 5
Homer A. Macapinlac
Close
Sort by
Journal Articles

Nonmyeloablative allogeneic transplantation with or without 90 yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year results

Clinical Trials & Observations
Issa F. Khouri, Rima M. Saliba, William D. Erwin, Barry I. Samuels, Martin Korbling, L. Jeffrey Medeiros, Rosamar Valverde, Amin M. Alousi, Paolo Anderlini, Qaiser Bashir, Stefan Ciurea, Alison M. Gulbis, Marcos de Lima, Chitra Hosing, Partow Kebriaei, Uday R. Popat, Nathan Fowler, Sattva S. Neelapu, Felipe Samaniego, Richard E. Champlin, Homer A. Macapinlac
Journal: Blood
Blood (2012) 119 (26): 6373–6378.
https://doi.org/10.1182/blood-2012-03-417808
Published: 2012
Journal Articles

Phase 2 study of rituximab plus ABVD in patients with newly diagnosed classical Hodgkin lymphoma

Clinical Trials & Observations
Anas Younes, Yasuhiro Oki, Peter McLaughlin, Amanda R. Copeland, Andre Goy, Barbara Pro, Lei Feng, Ying Yuan, Hubert H. Chuang, Homer A. Macapinlac, Fredrick Hagemeister, Jorge Romaguera, Felipe Samaniego, Michelle A. Fanale, Bouthaina Shbib Dabaja, Maria A. Rodriguez, Nam Dang, Larry W. Kwak, Sattva S. Neelapu, Luis E. Fayad
Journal: Blood
Blood (2012) 119 (18): 4123–4128.
https://doi.org/10.1182/blood-2012-01-405456
Published: 2012
Includes: Supplemental data
Journal Articles

Mature Results of BEAM/High-Dose Rituximab Vs BEAM/Yttrium-90 Ibritumomab Tiuxetan (Zevalin ® ) and Autologous Stem Cell Transplantation (ASCT) for Relapsed CD20+ Follicular and Diffuse Large B-Cell Lymphoma: Survival Outcomes and Risk of Secondary Malignancies

Lisa Zipp, MS, Rima M Saliba, Ph.D., Rosamar Valverde, Grace-Julia Okoroji, Martin Korbling, MD, Barry I Samuels, MD, Lynne V. Abruzzo, MD, PhD, Amin M Alousi, MD, Borje S Andersson, MD, PhD, Chitra M Hosing, MD, Bill Erwin, MS, Paolo Anderlini, MD, Uday R Popat, MD, Partow Kebriaei, Homer A Macapinlac, MD, Richard Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2011) 118 (21): 2005.
https://doi.org/10.1182/blood.V118.21.2005.2005
Published: 2011
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation with/ or without 90 yttrium Ibritumomab Tiuxetan ( 90 YIT) Is Curative for Relapsed Follicular Lymphoma: Median 9 Year Follow-up Results

Issa F Khouri, MD, Rima M Saliba, Ph.D., Rosamar Valverde, Barry I Samuels, MD, Martin Korbling, MD, Amin M Alousi, MD, Paolo Anderlini, MD, Qaiser Bashir, MD, Marcos De Lima, MD, Chitra Hosing, MD, Partow Kebriaei, MD, Yago Nieto, MD, PhD, Uday R Popat, MD, Muzaffar Qazilbash, MD, Sattva Neelapu, MD, Nathan H. Fowler, MD, Felipe Samaniego, MD, Luhua Wang, MD, Richard Champlin, MD, Homer A Macapinlac, MD
Journal: Blood
Blood (2011) 118 (21): 662.
https://doi.org/10.1182/blood.V118.21.662.662
Published: 2011
Journal Articles

Zevalin®/BEAM/Rituximab vs BEAM/Rituximab and Autologous Stem Cell Transplantation (ASCT) for Relapsed Chemosensitive Diffuse Large B-Cell Lymphoma (DLBCL): Impact of the IPI and PET Status.

Amin M. Alousi, MD, Chitra Hosing, M.D., Rima M. Saliba, PhD., Rosamar B. Valverde, BSN, Farzaneh Maadani, BS, Martin Korbling, M.D., Grace J. Okoroji, MS, Luis E. Fayad, M.D., Anne M. Stachowiak, BS, William D. Erwin, MS, Paolo Anderlini, M.D., Marcos J. de Lima, M.D., Sergio A. Giralt, M.D., Uday R. Popat, M.D., Partow Kebriaei, M.D., Naoto T. Ueno, M.D., Peter W. McLaughlin, M.D., Barbara Pro, M.D., Michael Wang, M.D., Alma Rodriguez, M.D., Fredrick B. Hagemeister, M.D., Homer A. Macapinlac, M.D., Donald A. Podoloff, M.D., Richard E. Champlin, M.D., Issa F. Khouri, M.D.
Journal: Blood
Blood (2007) 110 (11): 620.
https://doi.org/10.1182/blood.V110.11.620.620
Published: 2007